![Laura Aguilar](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Laura Aguilar
No más puestos en curso
Fortuna: 23 M $ al 30/09/2026
Perfil
Laura K.
Aguilar served as the Chief Medical Officer at Candel Therapeutics, Inc. from 2014 to 2022.
Prior to that, she worked at the same company from 2006.
Aguilar received her undergraduate degree from the University of California, Davis and her doctorate from Baylor College of Medicine.
Participaciones conocidas en empresas públicas
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 24/04/2026 | 2.193.961 ( 2,87 % ) | 23 M $ | 30/09/2026 |
Antiguos cargos conocidos de Laura Aguilar.
| Empresas | Cargo | Fin |
|---|---|---|
| CANDEL THERAPEUTICS, INC. | Director Técnico/Científico/I+D | 07/02/2022 |
Formación de Laura Aguilar.
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
20
Relaciones de 1er grado
3
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 3 |
|---|---|
University of California, Davis
 University of California, Davis Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Baylor College of Medicine
 Baylor College of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Candel Therapeutics, Inc.
 Candel Therapeutics, Inc. BiotechnologyHealth Technology Develops and distributes immunotherapies for the treatment of cancer | Health Technology |
- Bolsa de valores
- Insiders
- Laura Aguilar
